Available online at www.sciencedirect.com
DrugandAlcoholDependence96(2008)281–285
Shortcommunication
Mortality among injecting drug users in Melbourne: A 16-year follow-up
of the Victorian Injecting Cohort Study (VICS)
Mark A. Stoove´a,∗ , Paul M. Dietzea, Campbell K. Aitkena, Damien Jolleyb
aCentreforEpidemiologyandPopulationHealthResearch,MacfarlaneBurnetInstituteforMedicalResearchandPublicHealth,85CommercialRoad,
Melbourne,Victoria3004,Australia
bMonashInstituteofHealthServicesResearch,FacultyofMedicine,NursingandHealthSciences,MonashUniversity,Victoria3800,Australia
Received24January2008;receivedinrevisedform4March2008;accepted4March2008
Availableonline22April2008
Abstract
Multiplefactorsaffectinjectingdrug-relatedmortality,manyofwhichwillvaryovertimeandbetweenjurisdictions.Therearerelativelyfew
studiesofmortalityamonginjectingdrugusers(IDU)inAustralia.Weaimedtoprovidedatacomparabletothosereportedinternationallyonthe
rateofmortalityamongIDUinAustralia.Weretrospectivelyexaminedmortalityamongparticipants(N=220)fromthefirstAustraliancohort
studyofIDUbylinkingcodedpersonalidentifierrecordswithanationaldeathregister.Theoverallmortalityrateamongthosefollowed-upwas
0.83per100PY(95%CI,0.56–1.21per100PY).ThisrateislowerthanthosereportedinternationallybutcomparabletothelimitedAustralian
data from other cohorts of IDU. Mortality was higher among males, most common among those aged in their early thirties and drug-related
mortalityoccurredtypicallyaftersubstantialinjectingcareers.Extensiveexperienceofincarceration(≥3times)wasassociatedwithincreased
riskofmortality.TheseresultssuggestthatratesofmortalityamongAustralianIDUmaybelowerthanthosereportedinternationally,withlow
HIVprevalenceandAustralia’slong-heldharmreductionframeworkpotentiallycontributingtothisresult.Furtherstudiesusingdefinedcohorts
followedovertimeareneededtoexaminelong-termoutcomesamongIDUinAustralia.
©2008ElsevierIrelandLtd.Allrightsreserved.
Keywords: Mortality;Injectingdruguse;Cohortstudy;Datalinkage
1. Introduction istics related to drug policy environments (Burris et al., 2004;
Kerretal.,2007).
Injectingdrugusers(IDU)areatconsiderablygreaterriskof FewstudiesofmortalityamongIDUcohortshavebeencon-
morbidityandmortalitythantheirnon-injectingpeers(Warner- ducted in Australia, with most research focused on coronial
Smith et al., 2001). Characteristics such as gender and age data.Whilethesestudiesareimportant,theycannotdetermine
(Hickmanetal.,2003),psychosocialfactorssuchasunemploy- IDU mortality rates as the size of the population at risk is
mentandimprisonment(Brugaletal.,2005),doseandfrequency unknown.Giventhecomplexityofthefactorsdescribedabove
ofinjection(vanAmeijdenetal.,1999),medicalcomplications andvariationsinthecharacteristicsofIDUanddrugusingenvi-
from injecting drugs (Warner-Smith et al., 2001), and health- ronments internationally, we would expect to see differences
careanddrugtreatmentutilisation(Langendametal.,2001)are in rates of mortality between jurisdictions. Indeed, substan-
importantfactorsdeterminingmortalityriskamongIDU.Risk tial variations in mortality rates have been reported between
mayalsobeaffectedbystructuralandenvironmentalcharacter- countries and over time (EMCDDA, 1999). For this reason it
is important to understand IDU mortality in Australia, where
harmminimisationistheoverarchingdrugpolicy(Ritteretal.,
2004).
∗ Correspondingauthorat:CentreforEpidemiologyandPopulationHealth WeretrospectivelyexaminedmortalitywithintheVictorian
Research,MacfarlaneBurnetInstituteforMedicalResearchandPublicHealth,
Injecting Drug Users Cohort Study (VICS) of Australian IDU
POBox2284,Melbourne,Victoria3001,Australia.Tel.:+61385062301;
recruitedintheearly1990s.OuraimwastoprovideIDUmor-
fax:+61392822138.
E-mailaddress:stoove@burnet.edu.au(M.A.Stoove´). tality data comparable to those reported internationally and
0376-8716/$–seefrontmatter©2008ElsevierIrelandLtd.Allrightsreserved.
doi:10.1016/j.drugalcdep.2008.03.006
282 M.A.Stoove´etal./DrugandAlcoholDependence96(2008)281–285
examine characteristics associated with mortality in an Aus- data.Mortalitywasestimatedwithperson-years(PY)offollow-updetermined
traliancontext. fromfirstinterviewdatetoeitherdeathorcensorshipat18thSeptember2006.
Mortalityrateswerecalculatedusingstandardformulasandthestandardised
mortalityratio(SMR)wascalculatedindirectlyusingtime-specificageandsex
2. Methods
matchedAustralianpopulationdata.Characteristicsassociatedwithmortality
weredeterminedusingbivariateandmultivariateCoxregression.Criterionfor
2.1. VICS
theinclusionofpredictorsinregressionmodelswerebasedonacombinationof
bivariateresults,theoreticalimportanceinrelationtomortalityandtheoverall
VICS was the first longitudinal study of IDU conducted in Australia. A magnitudeofregressioncoefficients.
detaileddescriptionofVICSisreportedelsewhere(CroftsandAitken,1997). ThisstudywasapprovedbytheHumanResearchEthicsCommitteeofthe
Briefly,VICSwasalongitudinalstudyof626IDUrecruitedthroughthesocial DepartmentofHumanServices,StateGovernmentofVictoria.
networksof‘privilegedaccess’interviewers(PAIs;formerorcontinuingIDU
withextensiveexperienceoftheIDU“scene”)and‘snowballing’fromthese
networks. VICS PAIs interviewed participants at approximately nine-month 3. Results
intervalsbetween1990and1995,recordingdetaileddemographics,druguse
characteristicsandlifeevents.
Inassessingselectionbias,therewerefewstatisticallysignif-
icantdifferencesbetweenthemortalitycohortandtheremainder
2.2. Caseascertainment
of the VICS participants, except that the mortality cohort was
MortalitywasdeterminedusingNationalDeathIndex(NDI)matchingof more likely to have drug treatment experience and less likely
codeduniqueidentifiersextractedfromVICSrecords.Theseidentifiers,acom- to report government benefits as their primary income source
binationoflettersofparticipants’firstandsecondnames,genderanddatesof (neitherofwhichwereassociatedwithmortalityinthemortal-
birth,wereonlyavailablefor220participantsinterviewedbytwoPAIs,hereafter
itycohort).Characteristicsofthemortalitycohortsamplewere
referredtoasthemortalitycohort.Theremainingparticipantswereinterviewed
generallysimilartothoseofothersamplesofIDUrecruitedin
byotherPAIswhohadnotkepttherequisiterecordsorwerenolongercon-
tactable.Themortalitycohortwasrecruitedbetween21stJune1990and5th Australia(e.g.NCHECR,2007a).Themeanageofthemortality
September1994andfinalfollow-upinterviewswereconductedbetween19th cohortwas28years(S.D.=6.6),57%weremale,34%reported
November1990and12thOctober1995.Themediannumberofinterviewsper previousincarceration,and64%reportedheroinasthedrugthey
participantwasthree(IQR1–5),themediantimebetweenVICSinterviewswas
injectedmostatfinalVICSinterview.
253days(IQR163–435),withanaveragelengthofVICSfollow-upof2years.
Twenty-sixparticipantsdiedduringthefollow-upperiod.The
average age at death was 33 years (S.D.=6.33, min. 21, max.
2.3. Datamatching
46).Theoverallmortalityratewas0.83(95%CI,0.56–1.21)per
TheNDIcontainsrecordsofalldeathsinAustraliasince1980.TheNDI 100PY,withanSMRof6.08(95%CI,4.14–8.93),higheramong
comparedidentifiercodesfromthemortalitycohorttothosefromalldeaths males,andhighestamongthoseaged30–34years(Table1).
occurringbetween1990and18thSeptember2006.Dateofdeathandcause Drug overdose was the most common cause of death
ofdeathcodes(onlyprimaryunderlyingICD9codespriorto1997,thereafter
(14/26),producinganoverdosemortalityrateof0.44(95%CI,
primaryandallsecondaryICD10codes)frommatchedcasesweremergedinto
0.26–0.75)per100PY.Afurtherfourmortalitycaseswereprob-
theVICSdatabase.Overdosedeathsweredefinedascaseswhereaccidental
poisoning (ICD-10 X40-X49), intentional self-poisoning (ICD-10 X60-X64) ablyinjecting-related–oneeachofendocarditis,airembolism,
and/orpoisoningbydrugs/toxicsubstances(ICD-10T36-T65)wereassigned pulmonary embolism with thrombosis of deep lower extrem-
asprimaryorsecondarycausesofdeath. ityvessels,andopenwoundofhand(likelysepticaemia);their
additionproducedadrug-relatedmortalityrateof0.57(95%CI,
2.4. Analysis 0.36–0.91) per 100 PY. The average length of injecting career
atdeathwas17years(S.D.=7.05,min3.86,max29.79).
Selection bias was assessed by comparing characteristics (e.g. socio-
Inbivariateanalyses,beingmale(hazardratio(HR)=3.46;
demographics, current/past injecting characteristics, incarceration history) of
95%CI,1.30–9.16)andincarcerationthreetimesormorecom-
themortalitycohortwiththerestoftheVICScohortusingindependent-sample
t-tests for interval data and Wilcoxon–Mann–Whitney rank tests for ordinal pared to not at all at baseline interview (HR=2.96; 95% CI,
Table1
Overallmortalityratesoftheinjectingdrugusercohort
Numberincohort Deaths(%) Person-years Mortalityrateper100person-years Rateratio
Overall 95%CI RR 95%CI
Totalrate 220 26 3151 0.83 0.56–1.21
Sex
Female 96 5(19) 1430 0.35 0.15–0.84 1.00
Male 124 21(81) 1720 1.22 0.80–1.87 3.49 1.32–9.26
Ageinyears(baseline)
<25 79 10(38) 1123 0.89 0.48–1.66 1.00
25–29 59 8(31) 833 0.96 0.48–1.92 1.08 0.43–2.73
30–34 45 7(27) 624 1.12 0.54–2.35 1.26 0.48–3.31
35+ 37 1(4) 571 0.18 0.03–1.24 0.20 0.03–1.54
M.A.Stoove´etal./DrugandAlcoholDependence96(2008)281–285 283
Table2
UnadjustedandadjustedaCoxproportionalhazardratios
Number Deaths Unadjustedhazardratio 95%CI Adjustedahazardratio 95%CI
Sex
Female 96 5 1 1
Male 124 21 3.42 1.29–9.07 3.94 1.41–11.04
Ageinyears(baseline)
<25 69 10 1 1
25–29 51 8 1.08 0.43–2.73 0.62 0.23–1.68
30–34 37 7 1.24 0.47–3.26 0.57 0.18–1.80
35+ 36 1 0.20 0.03–1.52 0.07 0.08–0.61
Timesincarceratedinprison(baseline)
0 148 15 1 1
1–2 48 5 1.09 0.39–3.03 0.93 0.33–2.62
>2 24 6 2.96 1.14–7.71 3.36 1.10–10.25
a Adjustedforvariablesinthetable.
1.13–7.71)weretheonlyvariablesassociatedwithgreatermor- maintenance treatment on mortality (e.g. van Ameijden et al.,
talityrisk. 1999)andstudiesinEuropehavereportedmortalityratessimilar
DifferencesinsurvivalwereexploredusingCoxproportional (Langendametal.,2001)orlower(Brugaletal.,2005)thanthose
hazardsmodelling.Table2showsadjustedHRsforfactorsasso- reportedhereamongIDUenrolledinmethadonemaintenance.
ciated with mortality. Being male, aged less than 35 years at Whileitisdifficulttodrawconclusionsregardingrelationships
baselineandincarcerationthreetimesormoreatbaselinewere between broader ecological factors and IDU mortality, a harm
associatedwithhighermortalityrisk.HIVstatuswasnotasso- reduction framework and public health responses to injecting
ciatedwithmortality(HR=0.87(baseHIVnegative);95%CI, drugs,establishedearlyintheepidemiccycle,possiblyunderpin
1.13–7.71)andtheinclusionofHIVstatushadnoeffectonthe therelativelylowIDUmortalityratesinAustralianstudies.
coefficientsofothervariablesincludedinthemodel. Consistentwithpreviousresearch(e.g.Hickmanetal.,2003)
mortality rates were higher among males and those aged in
4. Discussion theirearlytomid-thirties.Drug-relatedmortalityalsotypically
occurredafterlengthyinjectingcareers.However,asshownin
Overallandoverdosemortalityratesinthiscohortwerelower the proportional hazards model, those aged 35 years and over
thanthosereportedinEuropeandtheUSA,whereoverallmor- at VICS recruitment were at substantially lower mortality risk
talityamongIDUovercomparableyearsrangelargelybetween overthefollow-upperiodcomparedtoyoungerparticipants.Itis
1–5 per 100 PY, but were typically in the order of 3 per 100 likelythatmanyoftheseolderparticipantseitherreducedtheir
PY (e.g. EMCDDA, 1999; Langendam et al., 2001; Vlahov et injecting frequency or ceased injecting at some point over the
al., 2004). A few previous Australian studies also show rela- post-VICSfollow-upperiod,somuchoftheirsignificantperiod
tively low mortality rates. A follow-up of methadone patients ofriskhadpassed.
(1976–1991)producedanoverallmortalityrateof1.12per100 More extensive experience of incarceration was associated
PYandanoverdosemortalityrateof0.61per100PY(Caplehorn withincreasedmortalityrisk.Othershavereportedassociations
etal.,1996).TheonlyotherAustraliancohortstudyofmortality betweencumulativelengthindetentionandnon-fataloverdose
retrospectivelyfollowedamphetamineandheroinusersadmit- risk(Ochoaetal.,2005;Sealetal.,2001),andmanystudieshave
ted to hospital and psychiatric institutions between 1985 and shownelevatedoverdosemortalityriskamongIDUduringthe
1998andreportedanoverallmortalityrateof1.57per100PY immediatepost-releaseperiod(e.g.BirdandHutchinson,2003;
(Bartu,2006;Bartuetal.,2004). Seamanetal.,1998).Thismortalityhasbeenlargelyattributed
Onepossiblereasonfortherelativelylowmortalityratefound tothelossofdrugtolerance(Seamanetal.,1998),althoughhigh
inthisandotherAustralianstudiesislowHIVprevalenceamong ratesofpost-releasenon-drug-relatedmortalityarealsoreported
AustralianIDU(NCHECR,2007b).StudiesinEurope(Brugal (Bird and Hutchinson, 2003). While we could not determine
et al., 2005; EMCDDA, 1999) and the USA (Vlahov et al., incarcerationhistorybetweenlastVICSinterviewandcensor-
2004)overcomparableperiodsreportconsiderableproportions ship, or the temporal relationship between prison release and
of AIDS deaths among IDU. However, even after removing mortality,ourfindingssuggestthatcausesotherthandrugover-
AIDS deaths from these studies, mortality rates from other dose were primarily responsible for the association between
causesremainhigherthanthosereportedhere.Thelowmortal- imprisonmentandmortality.Wefoundaloweroverdosemortal-
ityratefoundinthisstudymightresultfromhighparticipation ityriskcomparedtoall-causemortalityamongthoseimprisoned
rates in pharmacotherapy (Berbatis et al., 2000). Maintenance threetimesormore,whilemostoverdosedeaths(71%)occurred
pharmacotherapieshavebeenwidelyavailableandwell-utilised amongparticipantswithnoprisonhistoryatthetimeofVICS
in Victoria since the late 1980s (VGDHS, 2007). Research interviews.Othershavearguedthatlong-termhealthoutcomes
consistently demonstrates the protective effect of methadone of IDU with an incarceration history go beyond mortality and
284 M.A.Stoove´etal./DrugandAlcoholDependence96(2008)281–285
morbiditydirectlyattributabletodruguseandincludepsychoso- Funding: Funding for this study was provided by National
cialfactorsrelatedtopoorhealth,suchassocio-economicstatus, HealthandMedicalResearchCouncil(NMHRCProjectgrant);
homelessness,andpsychologicalstressassociatedwithre-entry theNHMRChadnofurtherroleinstudydesign,inthecollection,
intothecommunity(GaleaandVlahov,2002). analysisandinterpretationofdata,inthewritingofthereport,
Ourstudyislimitedinseveralways.First,wewereunableto orinthedecisiontosubmitthepaperforpublication.
includeallVICSparticipants.Theonlyselectionbiasesapparent Contributions:MarkStoove´wastheprincipalinvestigatoron
werethatthemortalitycohortwasmorelikelytohaveahistory thisstudy,wasresponsiblefordatamanagement,conductedthe
ofdrugtreatmentandlesslikelytoreportgovernmentbenefits statisticalanalysesandwasprimarilyresponsibletotheprepa-
astheirprimaryincomesourcecomparedtotheremainingVICS rationofthemanuscript.PaulDietzecontributedtotheresearch
participants.Boththesefactorsarepotentiallyprotectiveofmor- design, provided advice on the conduct of the research and
tality,somortalitymayhavebeenhigheramongtheremaining contributed to the writing of the manuscript. Campbell Aitken
VICSparticipants.Second,wemayhaveunder-ascertainedmor- provided advice during the conduct of the research, provided
tality cases because complete identifying information was not VICSdata,liaisedwithotherVICSresearchersandcontributed
available.Usingalpha-numericidentifiercodes,thisstudywas tothewritingofthemanuscript.DamienJolleyprovidedadvice
susceptibletoincorrectidentifyinginformation(eitherreported andguidanceonstatisticalanalysesandcontributedtothewrit-
byparticipantsorrecordedbyresearchers)affectingthereliabil- ingofthemanuscript.
ityofdatalinkage.Third,inretrospectivecohortstudiessuchas
this,eventsoccurringbetweenthelastfollow-upandcensorship
References
areunknown.Thisisparticularlyimportantwhenexploringcor-
relates of mortality and means that the predictors of mortality
Bartu,A.,Freeman,N.C.,Gawthorne,G.S.,Codde,J.P.,Holman,D.J.,2004.
reportedhereshouldbeinterpretedwithcaution.Forexample,
MortalityinacohortofopiateandamphetamineusersinPerth,Western
giventheassociationbetweenillicitdruginjectingandincarcer- Australia.Addiction99,53–60.
ation,someparticipantsarelikelytohavehadprisonexperience Bartu,A.,2006.Bartuetal.,2004:acorrection.Addiction101,1523–1524.
betweenthefinalinterviewanddatalinkage.Fourth,thepreci- Berbatis,C.G.,Sunderland,V.B.,Bulsara,M.,Lintzeris,N.,2000.Trendsinlicit
opioiduseinAustralia1984–1998:comparativeanalysisofinternationaland
sionofestimatesinthisstudywasaffectedbythesmallnumber
jurisdictionaldata.Med.J.Aust.173,524–527.
ofdeaths.Finally,overdoseanddrug-relatedmortalityratesmay
Bird,S.M.,Hutchinson,S.J.,2003.Maledrugs-relateddeathsinthefortnight
beunder-estimatedbecausepriorto1997onlytheprimarycause afterreleasefromprison:Scotland1996–99.Addiction98,185–190.
ofdeathwasrecordedintheNDIregister. Brugal,M.T.,Domingo-Salvany,A.,Puig,R.,Barrio,G.,GarciadeOlalla,P.,
Few studies have reliably estimated mortality rates among delaFuente,L.,2005.Evaluatingtheimpactofmethadonemaintenance
programmesonmortalityduetooverdoseandAIDSinacohortofheroin
AustralianIDU.ThescarcityofAustralianprospectivestudies
usersinSpain.Addiction100,981–989.
ofIDUhasproduceddeficienciesinourknowledgeofthenatural
Burris,S.,Blankenship,K.M.,Donaghoe,M.,Sherman,S.,Vernick,J.S.,Case,
history and long-term outcomes of IDU within the Australian P.,Lazzarini,Z.,Koester,S.,2004.Addressingthe“riskenvironment”for
context.Whilecohortstudiesareexpensiveandarelogistically injectiondrugusers:themysteriouscaseofthemissingcop.MilbankQ.82,
difficult to conduct with this population, better use of record 125–156.
Caplehorn,J.R.,Dalton,M.S.,Haldar,F.,Petrenas,A.M.,Nisbet,J.G.,1996.
linkagemethodsoffersaviablealternative.Ourstudysuggests
Methadonemaintenanceandaddicts’riskoffatalheroinoverdose.Subst.
thatmortalityratesamongAustralianIDUarelowerthanthose
UseMisuse31,177–196.
reportedinternationally.FurtherresearchwithotherAustralian Crofts,N.,Aitken,C.K.,1997.Incidenceofbloodbornevirusinfectionandrisk
cohortswillestablishthereliabilityofthesefindings. behavioursinacohortofinjectingdrugusersinVictoria,1990–1995.Med.
J.Aust.167,17–20.
EuropeanMonitoringCentreforDrugsandDrugAddiction(EMCDDA),1999.
Conflictsofinterest Co-ordinationofimplementation,follow-upandanalysisofcohortstudieson
mortalityamongdrugusersinEuropeanUnionMemberStates,EMCDDA
ScientificReport.Lisbon,Portugal.
Theauthorshavenoconflictsofinteresttodeclareinrelation
Galea,S.,Vlahov,D.,2002.Socialdeterminantsofthehealthofdrugusers:
tothisstudy.
socioeconomicstatus,homelessness,andincarceration.PublicHealthRep.
117(Suppl.1),s135–s145.
Hickman,M.,Carnwath,Z.,Madden,P.,Farrell,M.,Rooney,C.,Ashcroft,R.,
Acknowledgements
Judd,A.,Stimson,G.,2003.Drug-relatedmortalityandfataloverdoserisk:
pilotcohortstudyofheroinusersrecruitedfromspecialistdrugtreatment
TheauthorswouldliketoacknowledgeJohnHarding,Mark sitesinLondon.J.UrbanHealth80,274–287.
ShortandKunZhaofromtheAustralianInstituteofHealthand Kerr,T.,Fairbairn,N.,Tyndall,M.,Marsh,D.,Li,K.,Montaner,J.,Wood,E.,
2007.Predictorsofnon-fataloverdoseamongacohortofpolysubstance-
Welfare for their advice and assistance in facilitating the data
usinginjectiondrugusers.DrugAlcoholDepend.87,39–45.
linkage component of this study, Jenny Kelsall and Michael
Langendam,M.W.,vanBrussel,G.H.A.,Coutinho,R.A.,VanAmeijden,E.J.C.,
KergerwhocollectedtheoriginalVICSdatausedinthispaper 2001.Theimpactofharm-reduction-basedmethadonetreatmentonmortal-
and who kindly extracted participant identifying information, ityamongheroinusers.Am.J.PublicHealth91,774–780.
and finally Eulalio Ledesma for his advice in the preparation National Centre for HIV Epidemiology and Clinical Research (NCHECR),
2007a.AustralianNSPSurveyNationalDataReport,2002–2006.NCHECR,
of this manuscript. We would also like to thank Turning Point
Sydney.
AlcoholandDrugCentreforprovidinginfrastructuresupportto
NCHECR,2007b.HIV/AIDS,ViralHepatitisandSexuallyTransmissibleInfec-
undertakethisstudy. tionsinAustralia:AnnualSurveillanceReport,2007.NCHECR,Sydney.
M.A.Stoove´etal./DrugandAlcoholDependence96(2008)281–285 285
Ochoa,K.C.,Davidson,P.J.,Evans,J.L.,Hahn,J.A.,Page-Shafer,K.,Moss, vanAmeijden,E.J.C.,Langendam,M.W.,Coutinho,R.A.,1999.Dose–effect
A.R., 2005. Heroin overdose among young injection drug users in San relationshipbetweenoverdosemortalityandprescribedmethadonedosage
Francisco.DrugAlcoholDepend.80,297–302. in low-threshold maintenance programs. Addictive Behav. 24, 559–
Ritter,A.,Wodak,A.,Crofts,N.,2004.Reducingdrug-relatedharm:Australia 563.
leadstheway.Med.J.Aust.181,242–243. VictorianGovernmentDepartmentofHumanServices,2007.VictorianDrug
Seal,K.H.,Kral,A.H.,Gee,L.,Moore,L.D.,Bluthenthal,R.N.,Lorvick,J., StatisticsHandbook,2006.VictorianGovernmentDepartmentofHuman
Edlin,B.R.,2001.Predictorsandpreventionofnonfataloverdoseamong Services,Melbourne.
street-recruited injection heroin users in the San Francisco Bay Area, Vlahov,D.,Wang,C.,Galai,N.,Bareta,J.,Mehta,S.H.,Strathdee,S.A.,Nelson,
1998–1999.Am.J.PublicHealth91,1842–1846. K.E.,2004.Mortalityriskamongnewonsetinjectiondrugusers.Addiction
Seaman,S.R.,Brettle,R.P.,Gore,S.M.,1998.Mortalityfromoverdoseamong 99,946–954.
injectingdrugusersrecentlyreleasedfromprison:databaselinkagestudy. Warner-Smith,M.,Darke,S.,Lynskey,M.,Hall,W.,2001.Heroinoverdose:
Br.Med.J.316,426–428. causesandconsequences.Addiction96,1113–1125.
